Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

HSK 1 – For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languagesfree forever.

Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese.

By Bernd Sebastian Kamps and Andrea Melis

  Prostate Cancer

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    January 2026
  1. NG ABCD, Asif A, Kasivisvanathan V
    Biparametric vs Multiparametric MRI for Diagnosis of Prostate Cancer-Reply.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22866.
    PubMed    


  2. LOMBARDO R, Lorenti C, De Nunzio C
    Biparametric vs Multiparametric MRI for Diagnosis of Prostate Cancer.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22869.
    PubMed    


  3. PERERA MOLLIGODA ARACHCHIGE AS
    Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22872.
    PubMed    


  4. LIN HC, Chen HT, Chang CM
    Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis.
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.22863.
    PubMed    


    September 2025
  5. NG ABCD, Asif A, Agarwal R, Panebianco V, et al
    Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
    JAMA. 2025 Sep 10:e2513722. doi: 10.1001/jama.2025.13722.
    PubMed     Abstract available


    July 2025
  6. VOELKER R
    What Is Prostate Cancer?
    JAMA. 2025 Jul 24. doi: 10.1001/jama.2025.10177.
    PubMed    


  7. CATTO JWF, Murphy D, Loeb S
    Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.7941.
    PubMed    


  8. KINNAIRD A, Klotz L
    Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis-Reply.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.7944.
    PubMed    


  9. MIAO Y, Zhao K, Shang A
    Complexity of Prostate Cancer.
    JAMA. 2025 Jul 9. doi: 10.1001/jama.2025.7196.
    PubMed    


  10. RAYCHAUDHURI R, Lin DW, Montgomery RB
    Complexity of Prostate Cancer-Reply.
    JAMA. 2025 Jul 9. doi: 10.1001/jama.2025.7193.
    PubMed    


    March 2025
  11. KINNAIRD A, Luger F, Cash H, Ghai S, et al
    Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial.
    JAMA. 2025 Mar 23:e253579. doi: 10.1001/jama.2025.3579.
    PubMed     Abstract available


  12. RAYCHAUDHURI R, Lin DW, Montgomery RB
    Prostate Cancer: A Review.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.0228.
    PubMed     Abstract available


    November 2024
  13. AJJAWI I, Loeb S, Cooperberg MR, Catalona WJ, et al
    Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020.
    JAMA. 2024 Nov 20:e2420580. doi: 10.1001/jama.2024.20580.
    PubMed    


    August 2024
  14. TURNER EL, Metcalfe C, Martin RM
    PSA Screening and Prostate Cancer Mortality-Reply.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13809.
    PubMed    


  15. GOLDSTEIN MR, Mascitelli L
    PSA Screening and Prostate Cancer Mortality.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13806.
    PubMed    


  16. D'AMICO AV
    PSA Screening and Prostate Cancer Mortality.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13803.
    PubMed    


    July 2024
  17. NIK-AHD F, De Hoedt AM, Butler C, Anger JT, et al
    Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
    JAMA. 2024;332:335-337.
    PubMed    


    June 2024
  18. FENG X, Zahed H, Onwuka J, Callister MEJ, et al
    Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
    JAMA. 2024;331:1910-1917.
    PubMed     Abstract available


    May 2024
  19. NEWCOMB LF, Schenk JM, Zheng Y, Liu M, et al
    Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
    JAMA. 2024 May 30. doi: 10.1001/jama.2024.6695.
    PubMed     Abstract available


  20. HARRIS E
    Urine-Based Test Could Help Identify Aggressive Prostate Cancer.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.8424.
    PubMed    


  21. HARRIS E
    Prostate Cancer Cases Might Rise to 3 Million Globally by 2040.
    JAMA. 2024 May 3. doi: 10.1001/jama.2024.6729.
    PubMed    


    April 2024
  22. BAROCAS DA, Al Hussein Al Awamlh B, Koyama T
    Outcomes Following Localized Prostate Cancer Treatment-Reply.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5492.
    PubMed    


  23. HUANG TB, Ding XF
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5486.
    PubMed    


  24. CORNU JN
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5489.
    PubMed    


  25. AUVINEN A, Tammela TLJ, Mirtti T, Lilja H, et al
    Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
    JAMA. 2024 Apr 6:e243841. doi: 10.1001/jama.2024.3841.
    PubMed     Abstract available


  26. TOSOIAN JJ, Penson DF, Chinnaiyan AM
    A Pragmatic Approach to Prostate Cancer Screening.
    JAMA. 2024 Apr 6. doi: 10.1001/jama.2024.4089.
    PubMed    


  27. MARTIN RM, Turner EL, Young GJ, Metcalfe C, et al
    Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
    JAMA. 2024 Apr 6:e244011. doi: 10.1001/jama.2024.4011.
    PubMed     Abstract available


    January 2024
  28. AL HUSSEIN AL AWAMLH B, Wallis CJD, Penson DF, Huang LC, et al
    Functional Outcomes After Localized Prostate Cancer Treatment.
    JAMA. 2024;331:302-317.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum